Paliperidone added to antipsychotic drugs arsenal

摘要

Paliperidone,a new atypical antipsychotic medicine,has been launched this week by Janssen-Cilag.Branded as Invega and licensed for adults with schizophrenia,paliperidone is an active metabolite of risperidone.Paliperidone selectively blocks monoamine effects by binding strongly to serotonergic 5-HT2 and dopaminergic D2 receptors.